Why People Stop Taking nmn: Reasons, Safety, and What Research Shows
Updated October 23, 2026
If you searched “why I stopped taking NMN,” you may be looking for a personal story. This guide does not claim a verified first-hand NMN experiment. It explains practical reasons someone might pause or stop, what human studies have measured, and what remains unknown.
People may reconsider NMN if they do not notice a meaningful benefit, experience an unwanted effect, have concerns about long-term evidence, find the cost hard to justify, or receive advice from a healthcare professional. Current human studies offer some short-term safety information, but they do not prove that everyone benefits or establish long-term outcomes.
What human research can tell us
A 2026 systematic review and meta-analysis included 15 randomized trials of oral NMN or related preparations. Ten trials contributed safety data for 383 adults. Doses and study periods varied, from 250 to 2,000 mg per day and 14 days to 24 weeks. The review found no clear increase in overall or serious adverse events, withdrawals due to adverse events, or liver-enzyme elevations in the short-term trials. It also did not find broad, consistent improvements across several conventional metabolic measures. The authors emphasized that larger and longer studies are needed, so these results cannot rule out rare or long-term risks or promise a benefit for an individual.[1]
A few trials help show why a change in a biomarker should not be mistaken for a benefit every person can feel. These examples involved different populations and outcomes, so they do not establish a universal response or dose.
| Human study | What was measured | What the result does not show |
|---|---|---|
| 30 healthy adults; 250 mg/day for 12 weeks | Blood NAD+ increased. One NMN participant reported brief abdominal pain; no serious adverse events were reported.[2] | It did not test whether people would feel younger, have more energy, or live longer. |
| 25 postmenopausal women with overweight or obesity and prediabetes; 250 mg/day for 10 weeks | Blood-cell NAD+ and muscle insulin sensitivity increased in this small trial; fasting glucose and body composition did not significantly change.[9] | One selected population and one outcome cannot establish a diabetes treatment or predict results for other adults. |
| 48 recreational runners training 5–6 times per week; 300, 600, or 1,200 mg/day for 6 weeks | Some submaximal exercise measures improved in the medium- and high-dose groups alongside training; VO2max and peak power did not significantly improve.[10] | The finding does not establish an effect for people who are not trained runners or who do not follow the study's exercise program. |
A separate four-week safety study of 31 healthy adults evaluated 1,250 mg per day and reported no severe adverse events. Its small sample and short follow-up do not establish a preferred dose or long-term safety.[3]
Keep the evidence in proportion: Raising a blood NAD+ marker is not the same as proving a noticeable or lasting health benefit. The clinical trials cited here tested specific products, doses, populations, and time periods.
Reasons to reconsider or stop NMN
The points below are practical decision factors, not a ranking of how often people stop.
1. You do not notice a meaningful benefit
NMN is often discussed in connection with energy, skin, exercise, and aging, but these are not guaranteed outcomes. If you started it for a specific reason and cannot identify a meaningful change, it is reasonable to reassess the cost and uncertainty instead of increasing the amount or waiting for a promised “reboot.” Human research has not established a universal time at which someone should expect to feel a benefit. For a broader overview of the human NMN evidence, see AIDEVI’s NMN and healthy-aging evidence guide.
2. You notice an unwanted symptom
Short-term trial results are somewhat reassuring at the group level, but they cannot predict every person’s response. If you develop a symptom after starting NMN, write down when it began, what product and serving you used, and any other recent changes. Contact a healthcare professional if it is persistent or concerning; seek urgent help for a severe reaction. Do not restart simply to test a theory without discussing it with a professional.
3. You are unsure about long-term use
The available randomized-trial evidence is mainly short term. It does not establish what happens over many years, nor does it show that everyone needs ongoing NMN. If the reason you take it is unclear or the evidence no longer feels sufficient for you, you can review that choice with a healthcare professional.
4. The cost or product uncertainty is not worth it to you
A supplement’s price, label, and marketing do not prove that it produces a particular outcome. Read the Supplement Facts panel, serving size, and manufacturer information. Do not assume that a larger serving or a more complicated formula is more effective. The studies in the review used different doses; they do not validate a weight-based calculator or a universal personal dose.[1]
5. Your health situation or care plan has changed
Before using or restarting a supplement, speak with a clinician or pharmacist if you take medication, have a health condition, are pregnant or breastfeeding, or are preparing for a procedure. FDA advises consumers to discuss supplements with a healthcare professional because some supplements may interact with medicines. Do not use NMN instead of a prescribed treatment or delay medical care because of a supplement claim.[4]
Does stopping NMN cause withdrawal?
The clinical trials summarized here studied people while they were taking NMN; they do not establish a specific withdrawal syndrome or a standard tapering schedule. They also were not designed to answer every question about what people feel after stopping.[1][2][3] If your energy, sleep, or mood changes after a pause, that timing alone does not prove NMN withdrawal. Consider other changes and ask a healthcare professional if symptoms persist or concern you.
What does NMN’s regulatory status mean?
“FDA certified NMN as safe” is not an accurate description. The FDA does not approve dietary supplements before they are marketed.[4] In a September 2025 response, the FDA revised its interpretation of a drug-preclusion provision and concluded that NMN is not excluded from the statutory definition of a dietary supplement under that provision. This was an ingredient-status interpretation; it was not premarket approval, a safety certification, a recommended dose, or an endorsement of a specific brand or batch. Companies still have to meet applicable supplement requirements, and the FDA retains authority over products that are unsafe or otherwise unlawful.[5]
Rules also differ by region. In the EU, EFSA's 2026 safety opinion covered a specific chemically synthesized β-NMN ingredient proposed for supplements at up to 300 mg per day for adults, excluding pregnant and breastfeeding women. EFSA's opinion is a scientific safety assessment under those proposed conditions, not a general recommendation for NMN use.[6] As of October 23, 2026, the European Commission's draft authorizing act had received a positive committee opinion but was still listed as a draft act in the Comitology Register; check for the final regulation and its effective date before describing the ingredient as authorized for EU sale.[7] In Great Britain, the FSA register listed the β-NMN novel-food application as in progress at the risk-assessment stage.[8]
Online claims that NMN prevents cancer, causes cancer, reverses aging, or guarantees more energy also go beyond what the short human trials cited here can establish. Those studies were not designed to measure long-term cancer incidence, lifespan, or guaranteed changes in how a person feels.[1][2][3] If you have cancer or are receiving cancer treatment, ask your oncology team before using a supplement.
A practical way to decide what to do next
First separate a deliberate decision to stop from a routine that keeps breaking. If you chose to pause because the benefit was unclear, the cost felt unjustified, or you had a health concern, solve that question directly. If you still want to take NMN but often forget, a reminder or a stable daily cue may address the routine problem; it does not establish that NMN is beneficial or appropriate for you.
| What prompted the pause? | A useful next step |
|---|---|
| I did not notice a meaningful change. | Compare your original goal with outcomes human studies have actually measured. Do not raise the dose to chase an unproven feeling. |
| I developed a symptom. | Record when it started, the product and serving, and other changes. Ask a healthcare professional if it persists or concerns you; do not restart just to reproduce it. |
| The routine kept slipping. | If you have already decided NMN is appropriate for you, identify the missed cue or recurring disruption and choose one simple reminder or backup routine. |
| My medication, health situation, or care plan changed. | Ask your clinician or pharmacist before restarting or changing supplement use. Do not replace prescribed care with NMN. |
| The price or product information no longer feels worthwhile. | Review the label, serving size, and any batch-specific testing information you can verify. A certificate or notification is not a guarantee of clinical benefit. |
The following original lifestyle images are retained as illustrations. They do not show that these activities raise NAD+ in a clinically meaningful way, replace medical advice, or reproduce an NMN study outcome.
Frequently asked questions
Do I need to take NMN forever to maintain NAD+?
The human trials cited here do not establish that everyone needs ongoing NMN or that a person must take it indefinitely to maintain health. Talk with a healthcare professional if you are using it for a particular health concern.
Is NMN addictive?
The cited clinical trials were not designed to assess addiction or dependence. They do not establish that NMN is addictive, and they also do not provide a complete study of symptoms after stopping. Avoid treating an online personal story as proof either way.
Should I increase the dose if I do not feel anything?
No universal dose or escalation schedule has been established for a guaranteed subjective effect. Do not increase the amount to chase a promised result; review your goal and ask a healthcare professional if you are uncertain.
What should I do if I think NMN caused a symptom?
Record the symptom and timing, check the product label, and contact a healthcare professional if the symptom persists or concerns you. Seek urgent care for a severe reaction. Do not restart just to reproduce a symptom without medical advice.
References
- Yang W, Huang J, Tang Z, et al. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients. 2026;18(14):2251. Full article. doi:10.3390/nu18142251.
- Okabe K, Yaku K, Uchida Y, et al. Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects. Frontiers in Nutrition. 2022;9:868640. Full article. doi:10.3389/fnut.2022.868640.
- Fukamizu Y, Uchida Y, Shigekawa A, et al. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Scientific Reports. 2022;12:14442. Full article. doi:10.1038/s41598-022-18272-y.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. FDA.gov.
- U.S. Food and Drug Administration. Response to Citizen Petition, Docket FDA-2023-P-0872, September 29, 2025. FDA response letter.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens. Safety of beta-nicotinamide mononucleotide (β-NMN) pursuant to Regulation (EU) 2015/2283. EFSA Journal. 2026;24(5):e10007. EFSA opinion.
- European Commission. Draft Commission Implementing Regulation authorising β-NMN as a novel food, D118035/02; positive committee opinion dated September 24, 2026. Comitology Register.
- Food Standards Agency. Register of regulated product applications: β-Nicotinamide Mononucleotide, RP-2116. FSA application status.
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. PubMed. doi:10.1126/science.abe9985.
- Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Journal of the International Society of Sports Nutrition. 2021;18:54. PubMed. doi:10.1186/s12970-021-00442-4.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
